Document Detail


Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers.
MedLine Citation:
PMID:  22943633     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AIM: The present study evaluated the possibility of drug interactions involving blueberry juice (BBJ) and substrate drugs whose clearance is dependent on Cytochromes P450-3A (CYP3A) and P450-2C9 (CYP2C9). METHODS: A 50:50 mixture of lowbush and highbush BBJs was evaluated in vitro as an inhibitor of CYP3A activity (hydroxylation of triazolam and dealkylation of buspirone) and of CYP2C9 activity (flurbiprofen hydroxylation) using human liver microsomes. In clinical studies, clearance of oral buspirone and oral flurbiprofen was studied in healthy volunteers with and without co-treatment with BBJ. RESULTS: The BBJ inhibited CYP3A and CYP2C9 activity in vitro, with 50% inhibitory concentrations (IC50) of less than 2%, but without evidence of mechanism-based (irreversible) inhibition. Grapefruit juice (GFJ) also inhibited CYP3A activity, but inhibitory potency was increased by preincubation, consistent with mechanism-based inhibition. In clinical studies, GFJ significantly increased area under the plasma concentration-time curve (AUC) for the CYP3A substrate buspirone; the geometric mean ratio (GMR = AUC with GFJ divided by AUC with water) was 2.12. In contrast, the effect of BBJ (GMR = 1.39) was not significant. In the study of flurbiprofen (CYP2C9 substrate), the positive control inhibitor fluconazole significantly increased flurbiprofen AUC (GMR = 1.71), but BBJ had no significant effect (GMR = 1.03). CONCLUSION: The increased buspirone AUC associated with BBJ is quantitatively small and could have occurred by chance. BBJ has no effect on flurbiprofen AUC. The studies provide no evidence for concern about clinically important pharmacokinetic drug interactions of BBJ with substrate drugs metabolized by CYP3A or CYP2C9.
Authors:
Michael J Hanley; Gina Masse; Jerold S Harmatz; Paul F Cancalon; Gregory G Dolnikowski; Michael H Court; David J Greenblatt
Related Documents :
7930263 - Management outcome and follow-up of fetal tachycardia.
15306093 - Have sanctioned algorithms replaced empiric judgment in the selection process of antiar...
18316173 - In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-3
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  -     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Author. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
Affiliation:
Boston, Massachusetts, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of a weaning and extubation protocol to facilitate effective weaning and extubation from mec...
Next Document:  Evidence for the early clinical relevance of hallucinatory-delusional states in the general populati...